• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adjuvant chemotherapy for breast cancer--30 years later.

作者信息

Levine Mark N, Whelan Timothy

出版信息

N Engl J Med. 2006 Nov 2;355(18):1920-2. doi: 10.1056/NEJMe068204.

DOI:10.1056/NEJMe068204
PMID:17079767
Abstract
摘要

相似文献

1
Adjuvant chemotherapy for breast cancer--30 years later.乳腺癌辅助化疗——30年后
N Engl J Med. 2006 Nov 2;355(18):1920-2. doi: 10.1056/NEJMe068204.
2
Adjuvant therapy for early breast cancer.
N Engl J Med. 2007 Mar 22;356(12):1268-9. doi: 10.1056/NEJMc063408.
3
Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer.基质金属蛋白酶组织抑制因子-1（TIMP-1），一种预测原发性乳腺癌患者蒽环类辅助化疗反应的新型癌症生物标志物。
Eur J Cancer. 2009 Sep;45(14):2444-6. doi: 10.1016/j.ejca.2009.07.001. Epub 2009 Aug 3.
4
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.表柔比星、环磷酰胺、甲氨蝶呤和氟尿嘧啶作为早期乳腺癌的辅助治疗
N Engl J Med. 2006 Nov 2;355(18):1851-62. doi: 10.1056/NEJMoa052084.
5
HER2 and responsiveness of breast cancer to adjuvant chemotherapy.人表皮生长因子受体2（HER2）与乳腺癌对辅助化疗的反应性
N Engl J Med. 2006 May 18;354(20):2103-11. doi: 10.1056/NEJMoa054504.
6
Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.可手术乳腺癌初始辅助性环磷酰胺、甲氨蝶呤和氟尿嘧啶研究的经验教训。
J Clin Oncol. 2008 Jan 20;26(3):342-4. doi: 10.1200/JCO.2007.13.8149.
7
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.一项随机试验，比较环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）与交替使用CMF、表柔比星和长春新碱作为可手术乳腺癌的一线化疗方案。
Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678.
8
[Medical treatment of early breast cancer: chemotherapy].早期乳腺癌的医学治疗：化疗
Ugeskr Laeger. 2007 Sep 10;169(37):3070-2.
9
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.日本一项随机试验比较了环磷酰胺、表柔比星和氟尿嘧啶化疗与环磷酰胺、甲氨蝶呤和氟尿嘧啶在阳性淋巴结乳腺癌中的疗效。
Breast Cancer. 2010 Jul;17(3):190-8. doi: 10.1007/s12282-009-0132-x. Epub 2009 Jul 3.
10
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.采用环磷酰胺、甲氨蝶呤和氟尿嘧啶辅助化疗治疗的20多年来淋巴结阳性原发性乳腺癌的自然病史：癌症与白血病B组的一项研究
J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006.

引用本文的文献

1
Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.适配体武装纳米结构改善三阴性乳腺癌的化疗效果。
Mol Ther. 2022 Jun 1;30(6):2242-2256. doi: 10.1016/j.ymthe.2022.02.004. Epub 2022 Feb 8.
2
Th1 Immune Response Induction by Biogenic Selenium Nanoparticles in Mice with Breast Cancer: Preliminary Vaccine Model.生物源硒纳米颗粒在乳腺癌小鼠中诱导Th1免疫反应：初步疫苗模型
Iran J Biotechnol. 2015 Jun;13(2):1-9. doi: 10.15171/ijb.1056.
3
Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials.
基于脂质体阿霉素的化疗在晚期乳腺癌中的疗效和心脏毒性：十项随机对照试验的荟萃分析
PLoS One. 2015 Jul 23;10(7):e0133569. doi: 10.1371/journal.pone.0133569. eCollection 2015.
4
Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment.撤回：胰岛素样生长因子-1与化疗相关认知障碍的关系
Behav Brain Res. 2015 Feb 15;279:112-22. doi: 10.1016/j.bbr.2014.02.052. Epub 2014 Mar 12.
5
The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China.GSTP1 105Val 等位基因增加乳腺癌风险和侵袭性，但增强了华北地区对环磷酰胺化疗的反应。
PLoS One. 2013 Jun 24;8(6):e67589. doi: 10.1371/journal.pone.0067589. Print 2013.
6
Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer.富硒短双歧杆菌在体内引起更有效的免疫反应，并减少转移性乳腺癌小鼠模型中的肝转移。
Daru. 2013 Apr 30;21(1):33. doi: 10.1186/2008-2231-21-33.
7
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.评价有丝分裂器 17 获得和 HER2/拓扑异构酶 IIα 基因状态及蛋白表达在接受含蒽环类辅助化疗的乳腺癌患者中的预后作用：两个希腊肿瘤协作组（HeCOG）III 期临床试验的汇总分析。
BMC Cancer. 2013 Mar 28;13:163. doi: 10.1186/1471-2407-13-163.
8
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.美国成年人 1975-2008 年癌症化疗后治疗相关性急性髓系白血病的风险演变。
Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.
9
The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.非临床患者因素对肿瘤内科医生推荐乳腺癌辅助化疗决策的影响。
Breast Cancer Res Treat. 2012 Jul;134(2):867-74. doi: 10.1007/s10549-012-2116-3. Epub 2012 Jun 21.
10
Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies.MDR1 C3435T 多态性与晚期乳腺癌患者化疗反应之间缺乏关联：来自现有研究的证据。
Mol Biol Rep. 2012 May;39(5):5161-8. doi: 10.1007/s11033-011-1312-2. Epub 2011 Dec 9.